Leerink Partners Initiates Coverage on Rapport Therapeutics, Inc. Common Stock (RAPP) with Outperform
Rating Change Leerink Partners analysts initiated coverage on Rapport Therapeutics, Inc. Common Stock (NASDAQ:RAPP) with a Outperform rating on June 24, 2026. Market Context…
Read more
